Corrigendum to “Entrectinib in patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC) or NTRK fusion-positive solid tumours: Analysis of response by line of therapy”
Year: 2021
Type: erratum
Source: Annals of Oncology
Institutions: Georgetown University, Fondazione IRCCS Istituto Nazionale dei Tumori, Memorial Sloan Kettering Cancer Center, University of Minnesota, Yonsei University, Yonsei Cancer Hospital, Samsung Medical Center, Sungkyunkwan University, Taipei Veterans General Hospital, Massachusetts General Hospital, National Cancer Center Hospital East, National Cancer Center Hospital, University of California, Irvine, Centre Léon Bérard, National Cancer Centre Singapore, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, F. Hoffmann-La Roche AG, Genentech, University of Milan, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3127102000